Mary-Margaret Chren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary-Margaret Chren has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Anju P. Sahay
3 shared publications- Laura Prouty Sands
Department of Human Development and Center for Gerontology, Virginia Tech, Blacksburg
2 shared publications Rebecca J. Lasek
Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
2 shared publicationsBarry Gurland
Stroud Center, Columbia University, New York, New York
1 shared publicationDaniel Bertenthal
1 shared publication- Karla Lindquist
Department of Obstetrics, Gynecology & Reproductive Sciences University of California, San Francisco San Francisco California USA
1 shared publication
Latest Publications
- 1 October 2004
- Published by Wolters Kluwer Health in Medical Care
- Vol. 42 (10) , 1019-1026
Variation in Care for Nonmelanoma Skin Cancer in a Private Practice and a Veterans Affairs Clinic
Nonmelanoma skin cancer is the most common malignancy. Multiple therapies prevent recurrence but vary widely in cost. The most common therapies are local destruction, excision, and Mohs surgery (histologically guided tumor removal). Clinical variables that may affect treatment choices can be identified, but little is known about how clinicians choose among therapies. The objective of this study was to learn if variations exist in the treatment of nonmelanoma skin cancer in different practice settings. Prospective cohort study. Subjects consisted of consecutive patients with nonmelanoma skin cancer at a university-affiliated private dermatology practice and the dermatology clinic at the nearby affiliated Veterans Affairs (VA) medical center. We studied data from medical records and patient surveys. Overall, 1777 nonrecurrent nonmelanoma skin cancers were diagnosed in 1375 patients. Compared with the VA site, patients at the private site were younger, more likely to be female, and less likely to be poor, and their tumors were smaller and less likely to be on visible areas of the body. Treatments varied between the 2 sites (P <0.001). The proportions of tumors treated at the private and VA sites, respectively, were 23% and 19% for destruction, 25% and 48% for excision, and 37% and 25% for Mohs surgery. In multiple clinical subgroups, Mohs surgery was more likely to be performed at the private site than at the VA. Moreover, in multivariable models controlling for clinical features that may have affected treatment choice, tumors at the private site were more likely than tumors at the VA to be treated with Mohs surgery (odds ratio, 2.39; 95% confidence interval, 1.54-3.70). Care for nonmelanoma skin cancer varied at 2 academic practice sites that are near each other and that share some clinician staff. These findings raise questions not only about overuse or underuse of procedures at the 2 sites, but also about systematic differences in patient preferences and/or physician incentives in prepaid and fee-for-service settings.
- 1 October 2004
- Published by Wolters Kluwer Health in Medical Care
- Vol. 42 (10) , 1019-1026
Variation in Care for Nonmelanoma Skin Cancer in a Private Practice and a Veterans Affairs Clinic
Nonmelanoma skin cancer is the most common malignancy. Multiple therapies prevent recurrence but vary widely in cost. The most common therapies are local destruction, excision, and Mohs surgery (histologically guided tumor removal). Clinical variables that may affect treatment choices can be identified, but little is known about how clinicians choose among therapies. The objective of this study was to learn if variations exist in the treatment of nonmelanoma skin cancer in different practice settings. Prospective cohort study. Subjects consisted of consecutive patients with nonmelanoma skin cancer at a university-affiliated private dermatology practice and the dermatology clinic at the nearby affiliated Veterans Affairs (VA) medical center. We studied data from medical records and patient surveys. Overall, 1777 nonrecurrent nonmelanoma skin cancers were diagnosed in 1375 patients. Compared with the VA site, patients at the private site were younger, more likely to be female, and less likely to be poor, and their tumors were smaller and less likely to be on visible areas of the body. Treatments varied between the 2 sites (P <0.001). The proportions of tumors treated at the private and VA sites, respectively, were 23% and 19% for destruction, 25% and 48% for excision, and 37% and 25% for Mohs surgery. In multiple clinical subgroups, Mohs surgery was more likely to be performed at the private site than at the VA. Moreover, in multivariable models controlling for clinical features that may have affected treatment choice, tumors at the private site were more likely than tumors at the VA to be treated with Mohs surgery (odds ratio, 2.39; 95% confidence interval, 1.54-3.70). Care for nonmelanoma skin cancer varied at 2 academic practice sites that are near each other and that share some clinician staff. These findings raise questions not only about overuse or underuse of procedures at the 2 sites, but also about systematic differences in patient preferences and/or physician incentives in prepaid and fee-for-service settings.
- 1 March 2004
- Published by Elsevier in Journal of Investigative Dermatology Symposium Proceedings
- Vol. 9 (2) , 97-100
Conceptual Issues in Measuring the Burden of Skin Diseases
- 1 March 2004
- Published by Elsevier in Journal of Investigative Dermatology Symposium Proceedings
- Vol. 9 (2) , 97-100
Conceptual Issues in Measuring the Burden of Skin Diseases
- 1 February 2002
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 50 (2) , 263-268
Use of a Cane for Ambulation: Marker and Mitigator of Impairment in Older People Who Report No Difficulty Walking
Click on the article title to read more.
- 1 February 2002
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 50 (2) , 263-268
Use of a Cane for Ambulation: Marker and Mitigator of Impairment in Older People Who Report No Difficulty Walking
Click on the article title to read more.
- 1 March 2001
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 5 (2) , 105-110
Measurement Properties of Skindex-16: A Brief Quality-of-Life Measure for Patients with Skin Diseases
An accurate, sensitive, but brief quality-of-life outcomes measure is needed for studies of dermatologic care. To construct a single-page version of Skindex (a dermatologic quality-of-life instrument) that would have two new features compared with the current 29-item version: (1) fewer items to which a majority of patients choose the same response, and (2) measurement of bother rather than frequency of patient experiences. Random samples of patients waiting for dermatology appointments in clinics of Veterans Affairs hospitals and in private dermatology practices completed questionnaires; 692 patients responded to the parent instrument and 541 additional patients responded to the brief version. Reproducibility, internal consistency reliability, validity, and responsiveness of the brief version of Skindex were determined. For 16 items of the current 29-item version (55%), more than 50% of patients responded “Never.” After an explicit process of item analysis and elimination, a single-page 16-item version was composed that asks patients about bother from their experiences; responses are reported as three scales, Symptoms, Emotions, and Functioning. For 6 items of the 16-item version (38%), more than 50% of patients responded “Never.” Scale scores were reproducible after 72 hours (r = 0.88–0.90) and were internally reliable (Cronbach's a = 0.86–0.93). The instrument demonstrated both content and construct validity: Most patients' responses to an open-ended question about their skin disease was addressed by the items; patients with inflammatory dermatoses had higher scores than those with isolated lesions; and in an exploratory principal axes factor analysis with an oblique rotation, 74% of the common variance was explained by three factors that correlated with the a priori scales. Mean scale scores stayed the same or changed in the expected direction in patients who reported that their skin was the same or had improved. This brief single-page version of Skindex accurately and sensitively measures how much patients are bothered by their skin conditions.
- 1 March 2001
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 5 (2) , 105-110
Measurement Properties of Skindex-16: A Brief Quality-of-Life Measure for Patients with Skin Diseases
An accurate, sensitive, but brief quality-of-life outcomes measure is needed for studies of dermatologic care. To construct a single-page version of Skindex (a dermatologic quality-of-life instrument) that would have two new features compared with the current 29-item version: (1) fewer items to which a majority of patients choose the same response, and (2) measurement of bother rather than frequency of patient experiences. Random samples of patients waiting for dermatology appointments in clinics of Veterans Affairs hospitals and in private dermatology practices completed questionnaires; 692 patients responded to the parent instrument and 541 additional patients responded to the brief version. Reproducibility, internal consistency reliability, validity, and responsiveness of the brief version of Skindex were determined. For 16 items of the current 29-item version (55%), more than 50% of patients responded “Never.” After an explicit process of item analysis and elimination, a single-page 16-item version was composed that asks patients about bother from their experiences; responses are reported as three scales, Symptoms, Emotions, and Functioning. For 6 items of the 16-item version (38%), more than 50% of patients responded “Never.” Scale scores were reproducible after 72 hours (r = 0.88–0.90) and were internally reliable (Cronbach's a = 0.86–0.93). The instrument demonstrated both content and construct validity: Most patients' responses to an open-ended question about their skin disease was addressed by the items; patients with inflammatory dermatoses had higher scores than those with isolated lesions; and in an exploratory principal axes factor analysis with an oblique rotation, 74% of the common variance was explained by three factors that correlated with the a priori scales. Mean scale scores stayed the same or changed in the expected direction in patients who reported that their skin was the same or had improved. This brief single-page version of Skindex accurately and sensitively measures how much patients are bothered by their skin conditions.
- 1 March 2001
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 5 (2) , 105-110
Measurement properties of skindex-16: A brief quality-of-life measure for patients with skin diseases
An accurate, sensitive, but brief quality-of-life outcomes measure is needed for studies of dermatologic care.
- 1 March 2001
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 5 (2) , 105-110
Measurement properties of skindex-16: A brief quality-of-life measure for patients with skin diseases
An accurate, sensitive, but brief quality-of-life outcomes measure is needed for studies of dermatologic care.